Giddy-up: Novartis Weighs “White Knight” Options In Sanofi Bid For Aventis

A Novartis-Aventis combination would give the Franco-German firm a substantial consumer healthcare division to support the OTC sale of the allergy drug Allegra (fexofenadine) were Aventis to switch the drug from Rx status